Notícias · Recifes

Nearly 20% of new moms have anxiety or depression, but a promising psychedelic treatment i

About 1 in 5 women will experience depression and anxiety during pregnancy or in the year after giving birth. If untreated, a mother who has these conditions has a higher risk of birth complications, poorer overall health, impaired bonding and nurturing of her infant, and a highe

Admin Recifes 15/07/2026 8

First randomized controlled trial shows promise of a ketogenic diet in psychotic disorders

Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The s

Admin Recifes 15/07/2026 8

New experimental approach may help overcome drug resistance in deadly brain cancer

Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive forms of brain cancer: resistance to chemotherapy. The study shows that an experimental compound called BA-101 can restore the effective

Admin Recifes 15/07/2026 9

Anticancer 'nanoswitch' technology shows promise in animal model of triple-negative breast

A research team led by Professor Yoosoo Yang (Department of Integrative Biotechnology) of Sungkyunkwan University, in collaboration with the Korea Institute of Science and Technology (KIST) and Incheon National University, has developed a next-generation anticancer immunotherapy

Admin Recifes 15/07/2026 9

New non-invasive treatment shows promise for twin pregnancy complications

An innovative experimental procedure that uses high-energy sound waves to treat a rare and serious pregnancy condition called twin-twin transfusion syndrome (TTTS) is safe, according to an early-stage research trial involving U.K. and European patients.

Admin Recifes 15/07/2026 7

Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial

Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to substantial weight loss in people with Type 2 diabetes. The

Admin Recifes 15/07/2026 7

Inhibiting protein to treat myeloproliferative neoplasms shows preclinical promise

Inhibiting menin, a protein that supports leukemia growth and is already targeted to treat some forms of leukemia, also holds promise for treating myeloproliferative neoplasms. A new study from scientists at St. Jude Children's Research Hospital showed that inhibiting menin signi

Admin Recifes 15/07/2026 11

Body's own cell-to-cell messaging packets studied as the basis for next-generation medicin

The Blood and Tissue Bank is studying how to therapeutically manufacture and use a type of nanoparticles released by the body's cells to communicate with one another, in one of the most promising fields of research for the therapies of the future. New medicines and advanced thera

Admin Recifes 15/07/2026 8

Epigenetic therapy shows promise against treatment-resistant AML

Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effective in treatment-resistant acute myeloid leukemia (AML) by activating the Hippo pathway, a tumor-suppressing pathway linked to cancer growth

Admin Recifes 15/07/2026 9

Ureters stay visible for hours with dye designed to vanish through kidneys

A cross-disciplinary research team led by Hongjie Dai, director of the Materials Institute of Life Sciences and Energy (MILES) at the University of Hong Kong (HKU) in Shenzhen, has developed a promising near-infrared (NIR) fluorescent dye for potential clinical use in ureter imag

Admin Recifes 15/07/2026 10

Study shows promising outcomes for bariatric surgery in adolescents and young adults with

A new study from researchers at LSU's Pennington Biomedical Research Center, FMOL Health | Our Lady of the Lake Regional Medical Center and Metamor Institute demonstrates that metabolic and bariatric surgery can be delivered safely and effectively for adolescents and young adults

Admin Recifes 15/07/2026 6

New cancer drug shows promise in mesothelioma trial

Mesothelioma is a rare but aggressive cancer, usually caused by exposure to asbestos. Inhaled asbestos fibers become lodged in the lungs, causing inflammation that can lead to tumor formation decades later. Worldwide, about 30,000 people are diagnosed with mesothelioma each year.

Admin Recifes 15/07/2026 8

Acompanhe as Notícias da Recifes